480P CATRIPCA – A phase I of pembrolizumab (P) combined with Xevinapant (Debio 1143, (X)) in patients (pts) with non MSI-high advanced/metastatic pancreatic ductal adenocarcinoma (PDAC) or colorectal cancer (CRC)
Cassier, P.A., Terret, C., Voisin, A., Schiffler, C., Bidaux, A-S., Vanacker, H., Eberst, L., Lepercq, M.W., D'Argenio, A., M. Bernardin, Bouhamama, A., Gilles-Afchain, L., Treilleux, I., Tabone-Eglinger, S., Spaggiari, D., Chabaud, S., Grinberg-Bleyer, Y., Garin, G., Perol, D., Vinceneux, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
A phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions
Marabelle, A., Eberst, L., Terret, C., Pilleul, F., Mastier, C., Bouhamama, A., Gilles-Afchain, L., Laurent, S., Delzano, I., Reynaud, C., Caux, C., Garin, G., Bidaux, A.-S., Perol, D., Stojkowitz, N., Homerin, M., Leenders, H., Cassier, P.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors
Cassier, P., Eberst, L., Garin, G., Courbebaisse, Y., Terret, C., Robert, M., Frenel, J.-S., Depil, S., Delord, J.-P., Perol, D., Ray-Coquard, I.L., Bidaux, A.-S., Tabone-Eglinger, S., Gilles-Afchain, L., Treilleux, I., Wang, Q., Ducarouge, B., Mehlen, P., Blay, J.-Y., Gomez-Roca, C.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
439O - A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors
Cassier, P., Eberst, L., Garin, G., Courbebaisse, Y., Terret, C., Robert, M., Frenel, J.-S., Depil, S., Delord, J.-P., Perol, D., Ray-Coquard, I.L., Bidaux, A.-S., Tabone-Eglinger, S., Gilles-Afchain, L., Treilleux, I., Wang, Q., Ducarouge, B., Mehlen, P., Blay, J.-Y., Gomez-Roca, C.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
439OA first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors
Cassier, P, Eberst, L, Garin, G, Courbebaisse, Y, Terret, C, Robert, M, Frenel, J -S, Depil, S, Delord, J -P, Perol, D, Ray-Coquard, I L, Bidaux, A -S, Tabone-Eglinger, S, Gilles-Afchain, L, Treilleux, I, Wang, Q, Ducarouge, B, Mehlen, P, Blay, J -Y, Gomez-Roca, C A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
110TiPA phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions
Marabelle, A, Eberst, L, Terret, C, Pilleul, F, Mastier, C, Bouhamama, A, Gilles-Afchain, L, Laurent, S, Delzano, I, Reynaud, C, Caux, C, Garin, G, Bidaux, A-S, Perol, D, Stojkowitz, N, Homerin, M, Leenders, H, Cassier, P
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Magnetic sensor apparatus, system, and method
DUPRE NICOLAS, CLOSE GAEL, TOMBEZ LIONEL, GOYVAERTS DAVID, BIDAUX YVES
Year of Publication 26.02.2021
Get full text
Year of Publication 26.02.2021
Patent
Independent control of emission wavelength and output power of a semiconductor laser
AUDET ROSS M, ARBORE MARK ALAN, BISMUTO ALFREDO, MULLER ANTOINE JEAN ANDRE, BIDAUX YVES
Year of Publication 25.05.2021
Get full text
Year of Publication 25.05.2021
Patent